InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.600
-0.080 (-4.76%)
Oct 10, 2025, 2:36 PM EDT - Market open

InterCure Revenue

InterCure had revenue of 113.11M ILS in the half year ending December 31, 2024, a decrease of -45.14%. This brings the company's revenue in the last twelve months to 243.12M, down -10.84% year-over-year. In the year 2024, InterCure had annual revenue of 238.85M, down -32.82%.

Revenue (ttm)
243.12M ILS
Revenue Growth
-10.84%
P/S Ratio
1.08
Revenue / Employee
759,759 ILS
Employees
320
Market Cap
78.27M USD

Revenue Chart

* This company reports financials in ILS.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024238.85M-116.71M-32.82%
Dec 31, 2023355.55M-33.13M-8.52%
Dec 31, 2022388.68M169.01M76.93%
Dec 31, 2021219.68M154.64M237.78%
Dec 31, 202065.04M56.11M628.60%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings